Unknown NA INTERVENTIONAL 1-arm NCT02936011

DISsection RE-entry Evaluation With Absorb Bioresorbable Vascular Scaffolds in CTO. (DISCRETE-CTO)

DISsection RE-entry Evaluation With Absorb Bioresorbable Vascular Scaffolds in Chronic Total Occlusion. The DISCRETE CTO Study.

Sponsor: Belfast Health and Social Care Trust

Conditions Coronary Artery Disease

Interventions CTO PCI using Absorb Bioresorbable Vascular Scaffolds

Updated 6 times since 2017 Last updated: Oct 14, 2016 Started: Oct 31, 2016 Primary completion: Mar 31, 2018 Completion: Mar 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Coronary Artery Disease, this trial is ongoing. The trial is conducted by Belfast Health and Social Care Trust and has accumulated 6 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Apr 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Apr 2019 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Belfast Health and Social Care Trust
Bristol Royal Infirmary
Golden Jubilee National Hospital
Royal Infirmary of Edinburgh

Data source: Belfast Health and Social Care Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Belfast, United Kingdom